Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo | Predio dos Ambulatorios - Rheumatology Department

Research site

Site insights

Top conditions

Top treatments

Doxorubicin Hydrochloride

Parent organization

This site is a part of Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo

Data sourced from

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 4 total trials

A Study to Evaluate Change in Disease Activity of Subcutaneous (SC) Epcoritamab Combined With Intravenous and Oral Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone (R-CHOP) or R-CHOP in Adult Participants With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL) (EPCORE DLBCL-2)

B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). The purpose of t...

Diffuse Large B-Cell Lymphoma
Drug: Epcoritamab
Drug: Cyclophosphamide
Locations recently updated

Systemic Lupus Erythematosus (SLE) is an immune-mediated disease associated with inflammation of multiple organ systems. This study will assess how s...

Systemic Lupus Erythematosus
Drug: Upadacitinib
Drug: Placebo

Follicular Lymphoma (FL) is the second most common B-cell cancer and the most common type of cancer of lymphocytes. Unfortunately, this disease is in...

Follicular Lymphoma (FL)
Drug: Lenalidomide
Drug: Epcoritamab

Myelodysplastic Syndrome (MDS) is a group of disorders that gradually affect the ability of a person's bone marrow (semi-liquid tissue present in man...

Active, not recruiting
Myelodysplastic Syndrome (MDS)
Drug: Placebo
Drug: Azacitidine

Trial sponsors

AbbVie logo
Genmab logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems